Clinical Trialist Training Program

This page is designed to support both prospective applicants and current trainees in the ITMAT Clinical Trialist Training Program. 

While day to day materials and communications for CTTP trainees will be shared via Penn Box, this page offers general guidance, answers to frequently asked questions, and helpful links to support your journey before and after the program.

I do not currently work at Penn. Am I eligible for the program and/or scholarship?

  • Clinical Trialist Training Program participants must be employed at Penn upon entering the program.

What is the application timeline?

  • Applications are due February 28 for a July 1 start.

Are all academic tracks able to apply for this program?

  • Tenure, CE, and AC track faculty are encouraged to apply.

Are PhDs eligible for this program?

  • This program is geared toward physicians.

Are more advanced faculty eligible to apply?

  • Advanced faculty considering a pivot in their career to clinical trials will be considered.

Can I apply for this program if I am not seeking financial support?

  • We encourage you to apply. Please indicate your funding sources in your application and describe your interests in this program.

Can I apply for this program if I am seeking partial or up to 25% protected time to conduct clinical trials?

  • We encourage you to apply. Please indicate your percent effort being requested and describe your interests in this program.

What is the timeline from application to selection to start-date?

  • Applications are due February 28. Application review and interviews will take place in March-April. Trainees begin the program July 1.

All publications, press releases or other documents citing results from NIH-grant supported research must acknowledge the NIH grant support. For questions, please email Jessica German

Please include this language:

Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001878. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Public Access Policy

Submit all NIH-funded peer-reviewed, accepted manuscripts to be deposited in NIHMS at the time of acceptance for publication.

Starting July 1, 2025, final peer-reviewed journal manuscripts for work funded by the NIH must be submitted to PubMed Central immediately upon acceptance for publication.  

The National Institutes of Health (NIH) developed the NIH Manuscript Submission (NIHMS) system to facilitate the submission of peer-reviewed manuscripts for inclusion in the PubMed Central (PMC) in support of the NIH Public Access Policy.

Please link the UL1 grant to the publication:

1. THE EASIEST WAY is to manage this while you are submitting the manuscript to the journal. Most journals will ask if you've received NIH funding. Check 'yes' and they will likely help you comply with the policy and navigate the copyright agreement between the journal and the NIH. If you are unsure about this, ask your mentor or the journal.

2. Or, you can submit the manuscript yourself in the NIHMS system. *Make sure you have obtained the right to deposit the appropriate version of the manuscript* More about the NIH Manuscript Submission System here.

 

NIH Public Access Policy Guidance from the Penn Library

Penn's Human Research Protections Program (HRPP) 

  • Visit HRPP for IRB forms and templates, required training for human research at Penn, curated educational sessions offered by the Penn IRB, and guidance and resources for Penn IRB Board Members

One Penn Medicine, One Research 

  • This is your gateway to the Office of Clinical Research (OCR), Penn's central hub for clinical research. The "Scientists" tab includes training opportunities and access to cores and services that support Penn's clinical research mission. 
  • OCR is your go-to for study start-up, monitoring, INDs/IDEs, and regulatory support.
  • Executing clinical trials follows a defined sequence of steps and set of regulatory processes, these are described on the Clinical Research Execution page. 

ITMAT Center for Human Phenomic Science (CHPS) 

  • CHPS offers clinical and translational research resources, including space, space, and services. It's a complex resource - they recommend contacting a CHPS Facilitator to discuss your research needs.

ITMAT Investigational Drug Service (IDS)

  • IDS supports trials involving investigational products, natural products, biologics, and medical devices. If you're developing a protocol, contact the IDS during the planning phases.
Join the ITMAT Ed Clinical Trials Special Interest Group (SIG)

We encourage you to join the newly launched Clinical Trials SIG - a vibrant community of faculty, trainees, and staff committed to advancing investigator-initiated clinical trials or federally funded trials at Penn. As a trainee, this is your gateway to:

  • Networking with experienced clinical trialists across departments
  • Learning from real-world case studies and panelists
  • Collaborating on protocol development and trial design
  • Exploring career pathways in clinical trials